Why is Aarti Drugs falling/rising?

As of 29-Jul, Aarti Drugs Ltd is experiencing a price increase, currently at 538.85, reflecting a rise of 11.6 or 2.2%. The stock has shown resilience by outperforming its sector today by 0.79% and has reversed a two-day decline. It reached an intraday high of Rs 541.55, indicating positive momentum. Additionally, Aarti Drugs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bullish trend. Despite this positive movement, there has been a notable decline in investor participation, with delivery volume dropping by 65.29% compared to the 5-day average. The stock has delivered a return of 18.98% over the past month, while the benchmark Sensex has fallen by 3.24% during the same period.
In the broader market context, Aarti Drugs' recent performance contrasts sharply with the Sensex, which has declined by 1.03% over the past week. The company's strong management efficiency, indicated by a high return on capital employed (ROCE) of 17.84%, and a low debt-to-equity ratio contribute to its attractive valuation, making it appealing to investors. Furthermore, the stock's price is currently trading at a discount compared to its peers, which may attract more buyers. Over the past year, while the stock has generated a modest return of 7.07%, its profits have increased significantly by 20.4%, suggesting underlying strength that could support continued upward movement.